Xin-Ying Tang1,2, Nan Ru1,3, Qing Li4, Yang-Yang Qian1, Hui Sun1, Jia-Hui Zhu1, Lin He1,5, Yuan-Chen Wang1, Liang-Hao Hu1, Zhao-Shen Li1,3, Wen-Bin Zou1,3, Zhuan Liao6,7. 1. Department of Gastroenterology, Changhai Hospital, The Second Military Medical University, Shanghai, China. 2. Department of Prevention and Health Care, Eastern Hepatobiliary Surgery Hospital, The Second Military Medical University, Shanghai, China. 3. Shanghai Institute of Pancreatic Diseases, 168 Changhai Road, Shanghai, 200433, China. 4. Department of Gastroenterology, Taicang Affiliated Hospital of Soochow University, The First People's Hospital of Taicang, Taicang, Jiangsu Province, China. 5. Department of Gastroenterology and Endocrinology, PLA 969 Hospital, Inner Mongolia, China. 6. Department of Gastroenterology, Changhai Hospital, The Second Military Medical University, Shanghai, China. liaozhuan@smmu.edu.cn. 7. Shanghai Institute of Pancreatic Diseases, 168 Changhai Road, Shanghai, 200433, China. liaozhuan@smmu.edu.cn.
Abstract
BACKGROUND AND AIMS: The high incidence of osteopathy among patients with chronic pancreatitis (CP) has garnered increased attention over recent years. The aims of this study were to assess the prevalence and risk factors for osteopathy in Chinese patients with CP. METHODS: This was a cross-sectional study of CP patients from a large center in China; patients were recruited between 31 January 2017 and 31 January 2018. Bone density and laboratory tests, including bone-related biochemical, inflammatory, and hormone parameters, were assessed prospectively. Differences between patients with and without osteopathy were analyzed. Logistic regression analysis was used to investigate associations between variables. RESULTS: In total, 104 CP patients were enrolled in this study (68.3% idiopathic and 31.7% alcoholic). According to the M-ANNHEIM classification, 87.5% of the patients were at an early stage (0-II). Osteopenia was diagnosed in 30.8% of patients and osteoporosis in 5.8%; thus, a total of 36.5% of patients presented with osteopathy. In multivariate analysis, the independent risk factors for osteopathy in CP patients were age (OR = 1.04; 95% CI = 1.00-1.08; P = 0.030), BMI (OR = 0.72; 95% CI = 0.58-0.89; P = 0.003), and PTH (OR = 0.96; 95% CI = 0.93-1.00; P = 0.022). CONCLUSIONS: This study is the first to report the prevalence of osteopathy in Chinese patients with CP. It found that age and low BMI are significant risk factors for osteopathy. Low PTH (but within the normal range) showed a weak association with osteopathy, which warrants further exploration.
BACKGROUND AND AIMS: The high incidence of osteopathy among patients with chronic pancreatitis (CP) has garnered increased attention over recent years. The aims of this study were to assess the prevalence and risk factors for osteopathy in Chinese patients with CP. METHODS: This was a cross-sectional study of CP patients from a large center in China; patients were recruited between 31 January 2017 and 31 January 2018. Bone density and laboratory tests, including bone-related biochemical, inflammatory, and hormone parameters, were assessed prospectively. Differences between patients with and without osteopathy were analyzed. Logistic regression analysis was used to investigate associations between variables. RESULTS: In total, 104 CP patients were enrolled in this study (68.3% idiopathic and 31.7% alcoholic). According to the M-ANNHEIM classification, 87.5% of the patients were at an early stage (0-II). Osteopenia was diagnosed in 30.8% of patients and osteoporosis in 5.8%; thus, a total of 36.5% of patients presented with osteopathy. In multivariate analysis, the independent risk factors for osteopathy in CP patients were age (OR = 1.04; 95% CI = 1.00-1.08; P = 0.030), BMI (OR = 0.72; 95% CI = 0.58-0.89; P = 0.003), and PTH (OR = 0.96; 95% CI = 0.93-1.00; P = 0.022). CONCLUSIONS: This study is the first to report the prevalence of osteopathy in Chinese patients with CP. It found that age and low BMI are significant risk factors for osteopathy. Low PTH (but within the normal range) showed a weak association with osteopathy, which warrants further exploration.
Authors: April S Tignor; Bechien U Wu; Tom L Whitlock; Rocio Lopez; Kathryn Repas; Peter A Banks; Darwin Conwell Journal: Am J Gastroenterol Date: 2010-08-24 Impact factor: 10.864
Authors: Edmée C M Sikkens; Djuna L Cahen; Arjun D Koch; Henri Braat; Jan-Werner Poley; Ernst J Kuipers; Marco J Bruno Journal: Pancreatology Date: 2013-03-04 Impact factor: 3.996
Authors: Serena Stigliano; Alexander Waldthaler; Emma Martinez-Moneo; Luana Lionetto; Stuart Robinson; Marko Malvik; Aleksandra Hedstrom; Aleksandra Kaczka; Marius Scholdei; Stephan Haas; Maurizio Simmaco; Gianfranco Delle Fave; Matthias Lohr; Peter Simon; Gabriele Capurso Journal: Clin Transl Gastroenterol Date: 2018-10-15 Impact factor: 4.488